Summarize this patient's outcome trajectory and recent changes.

Protocol references found: - Selank is a synthetic analog of the immunomodulatory peptide tuftsin, approved in Russia for anxiety; Western evidence is limited. [1] - LL-37 is the only human cathelicidin-derived antimicrobial peptide and a central effector of innate immunity. It is generated by proteolytic cleavage of the hCAP18 precursor and is expressed by neutrophils, epithelial… [2] - DSIP (delta sleep-inducing peptide) is an endogenous neuropeptide associated with sleep modulation and stress resilience. Mechanism: incompletely understood; reported effects on sleep architecture, the HPA axis, and p… [3] - P21 (P021) is a neurotrophic peptide derived from a CNTF fragment, studied preclinically for neurogenesis and cognition. Mechanism: reported BDNF pathway activation and reduction of tau pathology in animal models. Rel… [4] - BPC-157 is a synthetic pentadecapeptide derived from a sequence identified in human gastric juice. The evidence base is predominantly preclinical (rodent models), with limited controlled human data. Mechanism. Report… [5] - Beyond direct killing, it is strongly immunomodulatory: it neutralizes lipopolysaccharide, recruits immune cells via formyl peptide receptors, and influences cytokine signaling. [6] - TB-500 is a synthetic fragment of Thymosin beta-4 (TB4), an actin-binding regulatory peptide. [7] - MOTS-c is a mitochondrial-derived peptide implicated in metabolic regulation. [8] This is decision support — a navigation of the cited sources, not a diagnosis, recommendation, or directive. Open the cited sources to verify.

Patient Nina Brooks (DEMO-009) has an active status with her latest assessment conducted on June 14, 2026. Recent lab results indicate concerns with high levels of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), with a total of 41 markers missing from the assessment [1]. In terms of her outcome trajectory, she has shown a clinical improvement score of 50 and a functional improvement score of 50. The metrics being tracked for her include fatigue score, brain fog score, pain score, sleep quality score, post-exertional malaise (PEM) score, and work capacity percentage [2]. This summary provides an overview of the patient's current status and recent changes, but remember, this is decision support, not a directive.